» Articles » PMID: 33602818

Genetic Priming of Sensory Neurons in Mice That Overexpress PAR2 Enhances Allergen Responsiveness

Overview
Specialty Science
Date 2021 Feb 19
PMID 33602818
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Pruritus is a common symptom of inflammatory skin conditions, including atopic dermatitis (AD). Although primary sensory neurons that transmit pruritic signals are well-cataloged, little is known about the neuronal alterations that occur as a result of skin disruption in AD. To address this question, we examined the molecular and behavioral consequences of challenging mice, which overexpress PAR2 in suprabasal keratinocytes, with serial topical application of the environmental allergen house dust mite (HDM). We monitored behavior and used RNA sequencing, qPCR, and in situ hybridization to evaluate gene expression in trigeminal ganglia (TG), before and after HDM. We found that neither nor wild-type (WT) mice exhibited spontaneous scratching, and pruritogen-induced acute scratching did not differ. In contrast, HDM exacerbated scratching in mice. Despite the absence of scratching in untreated mice, several TG genes in these mice were up-regulated compared to WT. HDM treatment of the mice enhanced up-regulation of this set of genes and induced additional genes, many within the subset of TG neurons that express TRPV1. The same set of genes was up-regulated in HDM-treated mice that did not scratch, but at lesser magnitude. Finally, we recorded comparable transcriptional changes in IL31Tg mice, demonstrating that a common genetic program is induced in two AD models. Taken together, we conclude that transcriptional changes that occur in primary sensory neurons in dermatitis-susceptible animals underlie a genetic priming that not only sensitizes the animal to chronic allergens but also contributes to pruritus in atopic skin disease.

Citing Articles

Molecular and cellular mechanisms of itch sensation and the anti-itch drug targets.

Sun M, Chen Z, Ding H, Feng J Acta Pharmacol Sin. 2024; 46(3):539-553.

PMID: 39424975 PMC: 11845708. DOI: 10.1038/s41401-024-01400-x.


Par2-mediated responses in inflammation and regeneration: choosing between repair and damage.

Reches G, Piran R Inflamm Regen. 2024; 44(1):26.

PMID: 38816842 PMC: 11138036. DOI: 10.1186/s41232-024-00338-1.


IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis.

Fassett M, Braz J, Castellanos C, Salvatierra J, Sadeghi M, Yu X Sci Immunol. 2023; 8(88):eabi6887.

PMID: 37831760 PMC: 10890830. DOI: 10.1126/sciimmunol.abi6887.


Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis.

Koumaki D, Gregoriou S, Evangelou G, Krasagakis K J Clin Med. 2023; 12(6).

PMID: 36983094 PMC: 10054239. DOI: 10.3390/jcm12062091.


Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries.

Reches G, Blondheim Shraga N, Carrette F, Malka A, Saleev N, Gubbay Y Inflamm Regen. 2022; 42(1):52.

PMID: 36447218 PMC: 9706915. DOI: 10.1186/s41232-022-00238-2.


References
1.
Yosipovitch G, Berger T, Fassett M . Neuroimmune interactions in chronic itch of atopic dermatitis. J Eur Acad Dermatol Venereol. 2019; 34(2):239-250. PMC: 7027518. DOI: 10.1111/jdv.15973. View

2.
Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K . Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci. 2000; 15(2):170-82. DOI: 10.1006/mcne.1999.0814. View

3.
Bonilla I, Tanabe K, Strittmatter S . Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci. 2002; 22(4):1303-15. PMC: 6757578. View

4.
Dembo T, Braz J, Hamel K, Kuhn J, Basbaum A . Primary Afferent-Derived BDNF Contributes Minimally to the Processing of Pain and Itch. eNeuro. 2019; 5(6). PMC: 6325548. DOI: 10.1523/ENEURO.0402-18.2018. View

5.
Hassler S, Kume M, Mwirigi J, Ahmad A, Shiers S, Wangzhou A . The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain. JCI Insight. 2020; 5(11). PMC: 7308051. DOI: 10.1172/jci.insight.137393. View